Your browser doesn't support javascript.
loading
Common variants in signaling transcription-factor-binding sites drive phenotypic variability in red blood cell traits.
Choudhuri, Avik; Trompouki, Eirini; Abraham, Brian J; Colli, Leandro M; Kock, Kian Hong; Mallard, William; Yang, Min-Lee; Vinjamur, Divya S; Ghamari, Alireza; Sporrij, Audrey; Hoi, Karen; Hummel, Barbara; Boatman, Sonja; Chan, Victoria; Tseng, Sierra; Nandakumar, Satish K; Yang, Song; Lichtig, Asher; Superdock, Michael; Grimes, Seraj N; Bowman, Teresa V; Zhou, Yi; Takahashi, Shinichiro; Joehanes, Roby; Cantor, Alan B; Bauer, Daniel E; Ganesh, Santhi K; Rinn, John; Albert, Paul S; Bulyk, Martha L; Chanock, Stephen J; Young, Richard A; Zon, Leonard I.
Afiliação
  • Choudhuri A; Harvard Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
  • Trompouki E; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
  • Abraham BJ; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
  • Colli LM; Department of Cellular and Molecular Immunology, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Kock KH; CIBSS Centre for Integrative Biological Signaling Studies, University of Freiburg, Freiburg, Germany.
  • Mallard W; Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
  • Yang ML; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Vinjamur DS; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Ghamari A; Department of Medical Imaging, Hematology, and Medical Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Sporrij A; Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Hoi K; Program in Biological and Biomedical Sciences, Harvard University, Cambridge, MA, USA.
  • Hummel B; Harvard Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
  • Boatman S; The Broad Institute of the Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.
  • Chan V; Division of Cardiovascular Medicine, Department of Internal Medicine and Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA.
  • Tseng S; Division of Hematology and Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Nandakumar SK; Division of Pediatric Hematology-Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Yang S; Harvard Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
  • Lichtig A; Harvard Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
  • Superdock M; Department of Cellular and Molecular Immunology, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Grimes SN; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
  • Bowman TV; Harvard Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
  • Zhou Y; Harvard Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
  • Takahashi S; Division of Hematology and Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Joehanes R; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
  • Cantor AB; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
  • Bauer DE; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
  • Ganesh SK; Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Rinn J; Summer Institute in Biomedical Informatics, Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
  • Albert PS; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
  • Bulyk ML; Albert Einstein College of Medicine, Bronx, NY, USA.
  • Chanock SJ; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
  • Young RA; Tohoku Medical and Pharmaceutical University, Sendai, Japan.
  • Zon LI; Hebrew Senior Life, Harvard Medical School, Boston, MA, USA.
Nat Genet ; 52(12): 1333-1345, 2020 12.
Article em En | MEDLINE | ID: mdl-33230299
ABSTRACT
Genome-wide association studies identify genomic variants associated with human traits and diseases. Most trait-associated variants are located within cell-type-specific enhancers, but the molecular mechanisms governing phenotypic variation are less well understood. Here, we show that many enhancer variants associated with red blood cell (RBC) traits map to enhancers that are co-bound by lineage-specific master transcription factors (MTFs) and signaling transcription factors (STFs) responsive to extracellular signals. The majority of enhancer variants reside on STF and not MTF motifs, perturbing DNA binding by various STFs (BMP/TGF-ß-directed SMADs or WNT-induced TCFs) and affecting target gene expression. Analyses of engineered human blood cells and expression quantitative trait loci verify that disrupted STF binding leads to altered gene expression. Our results propose that the majority of the RBC-trait-associated variants that reside on transcription-factor-binding sequences fall in STF target sequences, suggesting that the phenotypic variation of RBC traits could stem from altered responsiveness to extracellular stimuli.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenótipo / Fatores de Transcrição / Regulação da Expressão Gênica / Polimorfismo de Nucleotídeo Único / Eritrócitos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenótipo / Fatores de Transcrição / Regulação da Expressão Gênica / Polimorfismo de Nucleotídeo Único / Eritrócitos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
...